BP-One

product on market Tablet or Pill Patient One 1 MediNutritionals 🟢 Safety: 90/100
Brand: Patient One 1 MediNutritionals
🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 75% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
75% Evidence Coverage

Supplement Facts — Evidence Check

30 mcg (38% DV)
✅ Within RDA (0.2× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.03mg
800 mcg (200% DV)
✅ 2.0× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.8mg UL 1.0mg
250 mcg (4167% DV)
📊 104.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.25mg
Proprietary Blend
1435 mg

Other Ingredients

Dicalcium Phosphate Stearic Acid L-Leucine Croscarmellose Sodium Silicon Dioxide Aqueous Film coating

Label Claims — Verification

❓ All Other
❓ Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Suggested use: Take 2 tablets once daily as a dietary supplement, or as directed by a health professional.

⚠️ Warnings & Precautions

Contains: Milk and trace amounts of non-GMO soy

Caution: If pregnant, nursing, or taking any medications, consult doctor before use.

Discontinue use and consult if any adverse reactions occur.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Contains: Milk and trace amounts of non-GMO soy

Free of: Egg, fish, peanuts, crustacean shellfish (lobster, crab, shrimp), tree nuts, wheat, yeast, gluten, corn, sugar, and artificial sweeteners, flavors, colors, and preservatives. Free of ingredients derived from genetically modified organisms (GMOs).

Gluten free

Vegetarian

Additional Information

Helps maintain blood pressure already within normal range

Non GMO

Store in a cool, dry place and avoid excessive heat.

To refill please contact your practitioner or call 1-877-723-0777 or visit www.patientoneformulas.com

BPA free

Product Details

UPC / SKU 8 53959 00434 2
DSLD Entry Date 2019-08-23
Product Type Other Combinations
Form Tablet or Pill
Brand Patient One 1 MediNutritionals
DSLD ID 205568
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI
View all evidence for Vitamin K →

Compare Similar Products

Vitamin K 100 mcg
Vitamin K 100 mcg Vitamin World 100
Vitamin K2 Higher Nature 100
Vitamin K-1 The Vitamin Shoppe 100
Vitamin K1 100 mcg The Vitamin Shoppe 100
Vitamin K1 100 mcg Country Life 100
View all Vitamin K products →
Vitamin K research & evidence Best Vitamin K rankings All Vitamin K products More from Patient One 1 MediNutritionals View on NIH DSLD →